Display options
Cite
Taylor R, Raffa RB, Pergolizzi JV. Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature. J Pain Res. 2012;5:77-87doi: 10.2147/JPR.S21965.
Taylor, R., Raffa, R. B., & Pergolizzi, J. V. (2012). Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature. Journal of pain research, 577-87. https://doi.org/10.2147/JPR.S21965
Taylor, Robert, et al. "Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature." Journal of pain research vol. 5 (2012): 77-87. doi: https://doi.org/10.2147/JPR.S21965
Taylor R, Raffa RB, Pergolizzi JV. Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature. J Pain Res. 2012;5:77-87. doi: 10.2147/JPR.S21965. Epub 2012 Apr 23. PMID: 22570559; PMCID: PMC3346069.
Copy Download .nbib Format: NLM
Share it on

J Pain Res. 2012;5:77-87. doi: 10.2147/JPR.S21965. Epub 2012 Apr 23.

Controlled release formulation of oxycodone in patients with moderate to severe chronic osteoarthritis: a critical review of the literature.

Journal of pain research

Robert Taylor, Robert B Raffa, Joseph V Pergolizzi

Affiliations

  1. NEMA Research Inc, Naples, FL.

PMID: 22570559 PMCID: PMC3346069 DOI: 10.2147/JPR.S21965

Abstract

Osteoarthritis (OA) is a physically and emotionally debilitating disease that predominantly affects the aging adult population. Current pharmacologic treatment options primarily consist of nonsteroidal anti-inflammatory drugs and/or acetaminophen, but associated side effects, analgesic limitations, especially in the elderly, and the need for around-the-clock analgesia have led physicians to search for alternative analgesics. Opioids have shown effectiveness at mitigating both chronic cancer and noncancer pain, and their ability to be placed into controlled release (CR) formulations suggests that they may prove efficacious for OA patients. One formulation, oxycodone CR, has shown effectiveness in cancer pain patients and in some trials of noncancer low back pain. In this review, the objective was to synthesize the reported findings by researchers in this field and present an up-to-date look at the efficacy, safety, and tolerability of oxycodone CR in OA patients. Public literature databases were searched using specific keywords (eg, oxycodone CR) for studies assessing the efficacy and safety profile of oxycodone CR and its use in patients with OA. A total of eleven articles that matched the criteria were identified, which included three placebo-controlled trials, six comparative trials, one pharmacokinetic study in the elderly, and one long-term safety trial. Analysis of the studies revealed that oxycodone CR is reasonably efficacious, safe, and tolerable when used to manage moderate to severe chronic OA pain, with similar side effects to that of other opioids.

Keywords: controlled release; extended release; opioid; osteoarthritis; oxycodone

References

  1. CMAJ. 2006 May 23;174(11):1589-94 - PubMed
  2. Am J Ther. 2008 May-Jun;15(3):241-55 - PubMed
  3. Arch Intern Med. 2003 Jan 27;163(2):169-78 - PubMed
  4. Clin Drug Investig. 2010;30(8):489-505 - PubMed
  5. Adv Ther. 2010 Jun;27(6):381-99 - PubMed
  6. Am J Ther. 2000 Mar;7(2):75-90 - PubMed
  7. Br J Anaesth. 2012 Mar;108(3):491-8 - PubMed
  8. Drugs. 2003;63(1):17-32 - PubMed
  9. Pain. 1992 Apr;49(1):87-91 - PubMed
  10. Arthritis Rheum. 2008 Jan;58(1):26-35 - PubMed
  11. Arthritis Rheum. 2000 Sep;43(9):1905-15 - PubMed
  12. Pain. 1997 Oct;73(1):37-45 - PubMed
  13. Clin Ther. 2007 May;29(5):874-888 - PubMed
  14. Arthritis Res Ther. 2009;11(3):227 - PubMed
  15. J Clin Oncol. 1998 Oct;16(10):3222-9 - PubMed
  16. BMJ. 2004 Dec 4;329(7478):1317 - PubMed
  17. Clin J Pain. 2005 Nov-Dec;21(6):524-35 - PubMed
  18. Clin Geriatr Med. 2010 Aug;26(3):387-99 - PubMed
  19. Arch Intern Med. 2000 Mar 27;160(6):853-60 - PubMed
  20. Osteoarthritis Cartilage. 2007 Sep;15(9):981-1000 - PubMed
  21. Pain Pract. 2010 Sep-Oct;10(5):416-27 - PubMed
  22. Cochrane Database Syst Rev. 2006 Jan 25;(1):CD004257 - PubMed
  23. Curr Med Res Opin. 2006 Aug;22(8):1503-14 - PubMed
  24. J Gen Intern Med. 2007 Apr;22(4):485-90 - PubMed
  25. Jpn J Clin Oncol. 2004 Oct;34(10):608-14 - PubMed
  26. Expert Opin Drug Deliv. 2006 Jul;3(4):489-97 - PubMed
  27. J Pain. 2009 Feb;10(2):113-30 - PubMed
  28. Curr Rheumatol Rep. 2006 Feb;8(1):22-9 - PubMed
  29. Aging Clin Exp Res. 2003 Oct;15(5):359-63 - PubMed
  30. Am J Ther. 2001 May-Jun;8(3):181-6 - PubMed
  31. Rheumatology (Oxford). 2004 Feb;43 Suppl 1:i4-8 - PubMed
  32. J Fam Pract. 2011 Apr;60(4):206-12 - PubMed
  33. Clin Geriatr Med. 2010 Aug;26(3):355-69 - PubMed
  34. Curr Opin Rheumatol. 2002 Jan;14(1):63-71 - PubMed
  35. Hosp Pract (1995). 2011 Feb;39(1):62-73 - PubMed
  36. Clin Med Res. 2007 Mar;5(1):19-34 - PubMed
  37. J Clin Pharmacol. 2001 May;41(5):500-6 - PubMed
  38. Curr Opin Rheumatol. 2011 Sep;23(5):492-6 - PubMed
  39. Am J Epidemiol. 1995 Mar 15;141(6):539-45 - PubMed
  40. Patient. 2008 Jul 1;1(3):223-38 - PubMed
  41. Pain Pract. 2008 Jul-Aug;8(4):287-313 - PubMed
  42. Ann Rheum Dis. 2004 Aug;63(8):901-7 - PubMed
  43. Z Rheumatol. 1999 Jun;58(3):142-7 - PubMed
  44. Pain Med. 2009 Sep;10(6):1062-83 - PubMed
  45. BMJ. 2002 Sep 21;325(7365):624 - PubMed
  46. Am J Kidney Dis. 1996 Jul;28(1 Suppl 1):S3-6 - PubMed
  47. Osteoarthritis Cartilage. 2008 Apr;16(4):415-22 - PubMed
  48. Eur J Pain. 1998;2(3):239-49 - PubMed
  49. Pain Med. 2005 Sep-Oct;6(5):357-66 - PubMed
  50. Ann Intern Med. 2007 Oct 2;147(7):492-504 - PubMed
  51. J Rheumatol. 1999 Apr;26(4):862-9 - PubMed
  52. Pain Pract. 2011 May-Jun;11(3):230-9 - PubMed
  53. Am Fam Physician. 2000 Mar 15;61(6):1795-804 - PubMed
  54. Pain Med. 2011 May;12(5):755-60 - PubMed

Publication Types